Triple-Negative Breast Cancer
Oncology
7
Pipeline Programs
6
Companies
5
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
1
4
0
0
0
Early DiscoveryClinical DevelopmentMarket
Drug Modality Breakdown
Small Molecule
1100%
+ 6 programs with unclassified modality
Competitive Landscape
6 companies ranked by most advanced pipeline stage
GS
Gilead SciencesFOSTER CITY, CA
2 programs2
IMMU-132 infusion is administered to participants in one arm for the studyPhase 21 trial
IMMU-132 infusion is administered to participants in one arm for the studyPhase 2
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Chipscreen BiosciencesChiauranib
Gilead SciencesIMMU-132 infusion is administered to participants in one arm for the study
Alliance Pharmaceuticalsbrostallicin
Bristol Myers SquibbRomidepsin
CurisCUDC-907
Clinical Trials (5)
Total enrollment: 99 patients across 5 trials
A Phase II Study of Chiauranib in Combine With Capecitabine in TNBC
Start: Nov 2021Est. completion: Nov 2024
Phase 2Terminated
NCT02161679Gilead SciencesIMMU-132 infusion is administered to participants in one arm for the study
Phase II Study of IMMU-132 Alone or in Combination With Carboplatin in Patients With Triple-Negative Breast Cancer
Start: Aug 2016Est. completion: Aug 20160
Phase 2Withdrawn
Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer
Start: Jun 2010Est. completion: Nov 201448 patients
Phase 2Completed
Cisplatin Plus Romidepsin & Nivolumab in Locally Recurrent or Metastatic Triple Negative Breast Cancer (TNBC)
Start: Jul 2015Est. completion: Jul 202651 patients
Phase 1/2Active Not Recruiting
Open Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-907 in Subjects With Advanced/Relapsed Solid Tumors
Start: Nov 2014Est. completion: May 2019
Phase 1Completed
Related Jobs in Oncology
Senior Research Associate, Immuno-Oncology
SystImmune
8m ago
$60K - $85K/yr
Research Associate I/II, Immuno-Oncology
SystImmune
8m ago
Office Administrator
SystImmune
8m ago
$60K - $80K/yr
Scientist/Sr Scientist
TwoStep Therapeutics
San Carlos
18m ago
Working Student Office Management Support (m/f/d)
Mindpeak
Hamburg
22m ago
Senior Medical Project Manager (m/f/d)
Mindpeak
Hamburg
22m ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
6 companies competing in this space